Cited by 3Artificial Intelligence in Healthcare and EducationMachine Learning in HealthcareEthics and Social Impacts of AI

Validation is not enough: Longitudinal evidence of post-deployment fragility in clinical AI systems

Open access
Kopanitsa, Georgy·2026·PLOS Digital Health

Abstract

Pre-deployment validation is commonly used to establish the safety and effectiveness of clinical artificial intelligence systems, but acceptable validation performance does not guarantee stable behavior after deployment into routine clinical workflows. We conducted a longitudinal retrospective observational study of four clinically deployed AI systems operating across distinct clinical domains and workflows within a large healthcare organization. Using routinely collected clinical data, outcome labels, and operational telemetry, we compared validation-era performance with post-deployment behavior over extended observation periods. Analyses focused on temporal patterns of discrimination, calibration, data availability, latency, and workflow-related signals, with particular attention to label-dependent and label-independent monitoring. Across all systems, validation-era performance did not persist as a stable operational property after deployment. Calibration drift emerged consistently and often preceded detectable changes in discrimination. Workflow-associated changes in data availability and timing were more strongly and consistently associated with degradation than population-level indicators. Label-independent operational signals, including input missingness and data latency, provided early indication of emerging fragility, whereas outcome-based monitoring was delayed by label latency and documentation processes. These findings suggest that post-deployment fragility can be a structural property of clinical AI systems embedded in evolving workflows. Effective governance therefore requires lifecycle-oriented monitoring strategies that combine calibration reassessment with operational telemetry throughout deployment.

AI snapshot

Written from the paper’s full text.

TL;DR

In a longitudinal retrospective study of four clinically deployed AI systems, validation-era performance did not persist after deployment; calibration drift emerged earlier and more consistently than discrimination decline. Workflow-associated telemetry such as input missingness, data latency, and feature availability was more strongly associated with degradation than population-level indicators, supporting calibration-aware, telemetry-first post-deployment monitoring.

Key findings

  • Across Systems A–D, validation AUROC ranged from 0.80 to 0.86 and calibration slopes from 0.99 to 1.03; by mature deployment, AUROC fell to 0.75–0.82 and calibration slopes to 0.69–0.89, with calibration intercepts shifting negative (e.g., System A slope 1.01→0.71, intercept 0.02→−0.36; System B slope 0.99→0.69, intercept 0.01→−0.41).
  • Calibration changed earlier than discrimination: mean validation-to-early-deployment Δ calibration slope was −0.08, −0.11, and −0.14 for 3-, 6-, and 9-month early-deployment definitions, versus mean Δ AUROC of −0.01, −0.02, and −0.03.
  • Workflow-associated indicators showed stronger associations with calibration degradation than population indicators: input missingness βstd ranged from −0.42 to −0.21, data latency from −0.35 to −0.08, and feature availability change from −0.37 to −0.19, while population demographics ranged from −0.06 to −0.03. In leave-one-system-out analyses, telemetry blocks explained ΔR² 0.21–0.28 versus 0.05–0.07 for population blocks.
  • Three recurrent failure modes were identified: silent calibration failure under preserved discrimination, workflow-associated degradation without large population shift, and governance failure due to outcome-label latency.

Methods

  • Retrospective, longitudinal observational study of four clinically deployed AI systems (A–D) spanning acute-care EHR prediction, sepsis risk stratification, specialty outpatient diagnostic support, and radiology imaging-derived outcome risk; observation periods were 18–24 months and inference volumes ranged from 68,000 to 1,240,000 events. No model parameters, feature definitions, decision thresholds, or intended use changed during observation.
  • Performance was compared across validation, early deployment (first 6 months primary; sensitivity 3 and 9 months), and mature deployment (>6 months), using AUROC, AUPRC, calibration slope/intercept, and operational telemetry including input missingness, data latency, feature availability, inference volume, and interaction logs.
  • Analyses used monthly aggregation, bootstrap confidence intervals, mixed-effects linear regression with a system-level random intercept, lagged telemetry analyses, leave-one-system-out robustness, and alternative regression specifications; data came from EHR, laboratory, and imaging systems, with outcome labels from routine documentation and task-dependent delays.

Limitations

  • The paper states that empirical scope is limited to a finite set of systems within specific institutional contexts, so quantitative effect sizes and degradation rates should not be interpreted as universal; it also states that abstraction across heterogeneous tasks and modalities simplifies task-specific nuances.
  • The paper states that it did not prospectively elicit clinician tolerance thresholds or measure trust/reliance/abandonment, did not model organizational responses or label feedback, and does not evaluate compliance with specific regulatory frameworks or prescribe regulatory thresholds.
  • Evident from the text: only four anonymized systems were studied, vendor/model details are withheld, telemetry availability varied by system (e.g., alert acknowledgement/override was NA for Systems C and D), and the authors explicitly interpret drift associations as non-causal.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pdig.0001534

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

26 of 31 cited sources checked · 10 supported · 1 flagged · accuracy not yet measured

  • Premisecitation

    These frameworks primarily focus on evidence generation at the point of evaluation and provide limited guidance on how performance degradation should be detected and managed during routine clinical operation, particularly when outcome labels are delayed, incomplete, or influenced by the model's own use.

    “However, these frameworks primarily focus on evidence generation at the point of evaluation and provide limited guidance on how performance degradation should be detected and managed during routine clinical operation, particularly when outcome labels are delayed, incomplete, or influenced by the model’s own use [25–27].”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [25] SPIRIT-AI and CONSORT-AI Working Group, 2020, Guidelines for clinical trial protocols for interventions involving artificial intelligence: The SPIRIT-AI Extension, BMJ source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
    • cites [26] SE Davis, 2024, Sustainable deployment of clinical prediction tools-a 360° approach to model maintenance, J Am Med Inform Assoc source

      Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [27] V Subasri, 2025, Detecting and remediating harmful data shifts for the responsible deployment of clinical AI models, JAMA Netw Open source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • Premisecitation

    Care-process shifts, especially changes in test-ordering and documentation practices, can alter both feature availability and the meaning of missingness (informative missingness), which can affect deterioration-prediction performance even when underlying patient mix is relatively stable.

    “Care-process shifts – especially changes in test-ordering and documentation practices – can alter both feature availability and the meaning of missingness (“informative missingness”), which can affect deterioration-prediction performance even when underlying patient mix is relatively stable [11,12].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [11] T Sim, 2025, Preserving informative presence: How missing data and imputation strategies affect the performance of an ai-based early warning score, J Clin Med source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
    • cites [12] J Singh, 2021, On missingness features in machine learning models for critical care: Observational study, JMIR Med Inform source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • Premisecitation

    Clinical practice patterns learned from EHR data can vary substantially across years.

    “Clinical practice patterns learned from EHR data can vary substantially across years [6].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [6] JH Chen, 2017, Decaying relevance of clinical data towards future decisions in data-driven inpatient clinical order sets, Int J Med Inform source
  • Premisecitation

    Clinician interaction with decision support systems can recursively influence both inputs and outcomes, creating feedback loops that invalidate original performance assumptions.

    “Complementary work on alert fatigue and automation bias shows that clinician interaction with decision support systems can recursively influence both inputs and outcomes, creating feedback loops that invalidate original performance assumptions [19,20].”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [19] F Kücking, 2024, Automation bias in AI-decision support: Results from an empirical study, Stud Health Technol Inform source
    • cites [20] JS Ancker, 2017, Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system, BMC Med Inform Decis Mak source

      The Discussion reports that alert acceptance fell as the number of reminders and repeated reminders increased, supporting the narrower point that interaction with decision support is associated with clinician responses. It does not show that those responses recursively change system inputs or create feedback loops that invalidate performance assumptions. The Discussion also says the study did not support desensitization from repeated exposure over time. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Premisecitation

    External evaluations of widely deployed proprietary systems, such as the Epic Sepsis Model, have reported poor discrimination and calibration in routine clinical use despite broad adoption.

    “external evaluations of widely deployed proprietary systems, such as the Epic Sepsis Model, have reported poor discrimination and calibration in routine clinical use despite broad adoption [15,16].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [15] A Wong, 2021, External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients, JAMA Intern Med source
    • cites [16] P Papareddy, 2025, Transforming sepsis management: AI-driven innovations in early detection and tailored therapies, Crit Care source

      The Early Detection and Early Warning Systems section reports that the widely adopted Epic Sepsis Model had poor discrimination in independent validation (AUC about 0.63). The Foundational Issues section also reports that an external evaluation found it missed 67% of sepsis cases. The paper discusses poor calibration as a possible limitation of models generally, but does not report a finding of poor calibration for the Epic Sepsis Model specifically; page numbers are unavailable in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. 30
  • May combine two claims. 37
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim.

    Premisecitation

    Predictive systems that do not explicitly account for causal structure are brittle to policy and workflow changes, even when statistical properties appear similar.

    “Subbaswamy and Saria emphasize that predictive systems that do not explicitly account for causal structure are brittle to policy and workflow changes, even when statistical properties appear similar [18].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [18] A Subbaswamy, 2020, From development to deployment: dataset shift, causality, and shift-stable models in health AI, Biostatistics source

      The opening discussion describes a pneumonia-risk model that performed well on one dataset but was vulnerable to a subtle change in ICU admission policy. Sections 1 and 2 explain how causal graphs can identify susceptibility to policy and clinical-practice shifts. The paper does not establish the added claim that this brittleness persists when statistical properties appear similar. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Frameworks such as TRIPOD-AI and CONSORT-AI have substantially improved transparency in model development and validation, and regulatory bodies emphasize ongoing monitoring for AI/ML-enabled medical devices.

    “Frameworks such as TRIPOD-AI and CONSORT-AI have substantially improved transparency in model development and validation, and regulatory bodies emphasize ongoing monitoring for AI/ML-enabled medical devices [24].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [24] GS Collins, 2024, TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods, BMJ source

      The Discussion (page unavailable) says TRIPOD+AI provides reporting recommendations that can increase transparency, and the guideline table identifies CONSORT-AI as a reporting guideline. It does not establish that these frameworks have substantially improved transparency in practice. Its discussion of regulators concerns assessing reports submitted for medical-device review, not regulatory emphasis on ongoing monitoring. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Regulatory and reporting guidance increasingly acknowledges the need for lifecycle-based evaluation of AI systems.

    “Regulatory and reporting guidance increasingly acknowledges the need for lifecycle-based evaluation of AI systems [21–23].”
    Quote in the paperNot a substantial claim1 of 3 sources checked
    • cites [21] AA Armoundas, 2026, Total product lifecycle regulatory considerations and recommendations for generative AI-enabled medical devices, Eur Heart J Digit Health source

      The Risks and risk management section describes EU AI Act requirements for living documentation, lifecycle logging, post-market monitoring, and robustness assessment throughout the lifecycle. This supports the regulatory part of the claim, but the paper does not establish that reporting guidance increasingly acknowledges lifecycle-based evaluation. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites [22] FDA. Artificial intelligence-enabled device software functions: lifecycle management and marketing submission recommendations.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [23] Final Document Good machine learning practice for medical device development: Guiding principles AUTHORING GROUP Artificial Intelligence/Machine Learning-enabled Working Group Preface 2025.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationown data

    Calibration failure is structural and progressive rather than sporadic.

    “This extends prior reports of temporal miscalibration [32–34] by showing calibration failure is structural and progressive rather than sporadic.”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [32] SE Davis, 2020, Detection of calibration drift in clinical prediction models to inform model updating, J Biomed Inform source
    • cites [33] ES Andersen, 2024, Monitoring performance of clinical artificial intelligence in health care: A scoping review, JBI Evid Synth source
    • cites [34] SE Davis, 2017, Calibration drift in regression and machine learning models for acute kidney injury, J Am Med Inform Assoc source
  • May combine two claims.

    Premisecitation

    Recent omics-based diagnostic models illustrate both the promise of transferring single-cell or molecular signatures across bulk and single-cell sequencing data and the dependence of such models on platform compatibility, normalization, and cohort-specific processing choices.

    “Recent omics-based diagnostic models illustrate both the promise of transferring single-cell or molecular signatures across bulk and single-cell sequencing data and the dependence of such models on platform compatibility, normalization, and cohort-specific processing choices [45–47].”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [45] X Zheng, 2024, scCaT: An explainable capsulating architecture for sepsis diagnosis transferring from single-cell RNA sequencing, PLoS Comput Biol source

      Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
    • cites [46] R Wang, 2022, Improving bulk RNA-seq classification by transferring gene signature from single cells in acute myeloid leukemia, Brief Bioinform source
    • cites [47] N Jin, 2024, PAGE-based transfer learning from single-cell to bulk sequencing enhances model generalization for sepsis diagnosis, Brief Bioinform source
  • May combine two claims.

    Findingown data

    Calibration drift emerged consistently across the four systems and often preceded detectable changes in discrimination.

    “Calibration drift emerged consistently and often preceded detectable changes in discrimination.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In Systems A and B, AUROC remained close to validation levels during early deployment, whereas calibration slopes declined and calibration intercepts shifted.

    “In Systems A and B, AUROC remained close to validation levels during early deployment, whereas calibration slopes declined and calibration intercepts shifted.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Data latency was negatively associated with calibration slope in Systems A, B, and D, but not System C.

    “| Data latency | -0.35 (-0.49 to -0.21) | -0.27 (-0.40 to -0.13) | -0.08 (-0.18 to 0.02) | -0.23 (-0.36 to -0.10) |”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Operational telemetry indicators (input missingness, data latency, feature availability) validly capture workflow-induced drift and are not merely proxies for other unmeasured factors.
  • The quote only partly states this claim.

    Findingown data

    Operational telemetry changed over the same period as performance degradation.

    “Operational telemetry changed over the same period.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Outcome prevalence shift was negatively associated with calibration slope in Systems A and B, but not Systems C and D.

    “| Outcome prevalence shift | -0.18 (-0.28 to -0.08) | -0.16 (-0.26 to -0.06) | -0.07 (-0.16 to 0.02) | -0.08 (-0.18 to 0.01) |”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Outcome labels derived from routine clinical documentation are accurate and consistent enough to serve as ground truth for performance evaluation.
  • May combine two claims.

    Findingown data

    In mature deployment, calibration degradation was more pronounced across Systems A-C, while System D showed a larger decline in discrimination.

    “In mature deployment, calibration degradation was more pronounced across Systems A–C, while System D showed a larger decline in discrimination.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Feature availability change preserved the expected direction in most specifications, whereas population demographics showed a small coefficient range, lower incremental explained variance, and inconsistent direction.

    “Feature availability change preserved the expected direction in most specifications, whereas population demographics showed a small coefficient range, lower incremental explained variance, and inconsistent direction.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Population demographics showed weak and inconsistent associations across all systems, while outcome prevalence showed modest associations in Systems A and B.

    “Population demographics showed weak and inconsistent associations across all systems, while outcome prevalence showed modest associations in Systems A and B.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingnone given

    Validation-era performance met predefined acceptance criteria for all systems and served as the reference for post-deployment comparison.

    “Validation-era performance met predefined acceptance criteria for all systems and served as the reference for post-deployment comparison.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Missingness increases were not uniform across feature types; in Systems A and B, the largest increases occurred in time-sensitive EHR inputs, while in Systems C and D, missingness increases were smaller but concentrated in task-specific inputs.

    “Missingness increases were not uniform across feature types. In Systems A and B, the largest increases occurred in time-sensitive EHR inputs, including recent vital-sign observations, laboratory values pending at inference time, and structured documentation fields dependent on clinical workflow completion.”
    • Also stated in: § 3.4. Longitudinal performance and telemetry trajectories · plain
      “In Systems C and D, missingness increases were smaller but were concentrated in task-specific inputs, including delayed laboratory availability and incomplete imaging-derived feature extraction.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Operational telemetry, including missingness and latency, was observable at inference time, while outcome labels became available only after task-dependent delays ranging from days to months.

    “Operational telemetry, including missingness and latency, was observable at inference time, while outcome labels became available only after task-dependent delays ranging from days to months (Table 5; Figs 3–4).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Longitudinal estimates were repeated using alternative temporal aggregation windows; shorter windows increased variability, especially in lower-volume systems, whereas wider windows reduced short-term fluctuation.

    “Longitudinal estimates were repeated using alternative temporal aggregation windows. Shorter windows increased variability, especially in lower-volume systems, whereas wider windows reduced short-term fluctuation.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    System C showed slower calibration drift, while System D exhibited greater discrimination sensitivity to modality-specific workflow changes.

    “System C showed slower calibration drift, while System D exhibited greater discrimination sensitivity to modality-specific workflow changes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Validation-to-early-deployment differences in calibration slope were already evident using the 3-month definition and increased modestly under the 6- and 9-month definitions.

    “Validation-to-early-deployment differences in calibration slope were already evident using the 3-month definition and increased modestly under the 6- and 9-month definitions.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Missingness and latency remained negatively associated with calibration slope in all exclusions, and workflow-associated indicators retained greater explanatory contribution than population-related indicators.

    “Missingness and latency remained negatively associated with calibration slope in all exclusions, and workflow-associated indicators retained greater explanatory contribution than population-related indicators (Table 2).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Study design and conductnone given

    No changes were made to model parameters, feature definitions, decision thresholds, or intended use during the observation period.

    “No changes were made to model parameters, feature definitions, decision thresholds, or intended use during the observation period.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Outcome labels were derived from routine clinical documentation and were consistent with those used during validation.

    “Outcome labels were derived from routine clinical documentation and were consistent with those used during validation.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisereasoning

    Calibration slope was selected a priori as the primary dependent variable because calibration reflects the reliability of absolute risk estimates used in threshold-based clinical decision support.

    “The primary dependent variable for drift-association analyses was calibration slope, selected a priori because calibration reflects the reliability of absolute risk estimates used in threshold-based clinical decision support.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Minimal preprocessing was applied, and feature handling remained consistent with original model implementation.

    “Minimal preprocessing was applied, and feature handling remained consistent with original model implementation.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    All systems were evaluated as implemented within existing clinical workflows.

    “All systems were evaluated as implemented within existing clinical workflows.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    The failure modes were derived from the combined evidence in Tables 1, 4, 5 and Figs 1-4.

    “These failure modes were derived from the combined evidence in Tables 1, 4, 5 and Figs 1–4.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Validation should be treated as a conditional snapshot tied to the historical workflow, documentation, and data-pipeline context, challenging the assumption in reporting and procurement that acceptable validation metrics bound future operational risk.

    “Validation should therefore be treated as a conditional snapshot tied to the historical workflow, documentation, and data-pipeline context, challenging the assumption in reporting and procurement that acceptable validation metrics bound future operational risk.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    Existing literature establishes a clear consensus that model degradation is expected, common, and potentially harmful.

    “Taken together, existing literature establishes a clear consensus that model degradation is expected, common, and potentially harmful.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    In threshold-based workflows, miscalibration can change the number of patients crossing escalation thresholds, alter alert burden, or create false reassurance, even when AUROC remains within an apparently acceptable range.

    “In threshold-based workflows, such miscalibration can change the number of patients crossing escalation thresholds, alter alert burden, or create false reassurance, even when AUROC remains within an apparently acceptable range.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Across systems, the failure modes shared a common structure: degradation was progressive, often appeared first in calibration and operational telemetry, and could remain insufficiently visible under discrimination-focused or outcome-label-dependent monitoring.

    “Across systems, the failure modes shared a common structure: degradation was progressive, often appeared first in calibration and operational telemetry, and could remain insufficiently visible under discrimination-focused or outcome-label-dependent monitoring.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Premisereasoning

    What remains insufficiently understood is how degradation manifests during real-world deployment, which drift mechanisms are most influential under routine operating conditions, and which observable signals provide early warning of safety-relevant failure.

    “What remains insufficiently understood is how degradation manifests during real-world deployment, which drift mechanisms are most influential under routine operating conditions, and which observable signals provide early warning of safety-relevant failure.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    The finding should be interpreted as evidence that workflow-associated telemetry was more closely aligned with degradation in this dataset, not as evidence that population change was absent or irrelevant.

    “The finding should be interpreted as evidence that workflow-associated telemetry was more closely aligned with degradation in this dataset, not as evidence that population change was absent or irrelevant.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    These analyses were interpreted as associations between covariate blocks and performance degradation, not as causal decomposition.

    “These analyses were interpreted as associations between covariate blocks and performance degradation, not as causal decomposition.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    All data sources were linked at the inference level and temporally aligned relative to prediction time.

    “All data sources were linked at the inference level and temporally aligned relative to prediction time.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisereasoning

    Prior work generally does not address three interrelated questions central to governance: when degradation begins relative to deployment, which observable signals precede outcome-measured failure, and how governance constraints shape observability.

    “Despite the breadth of systems represented in Table 7, prior work generally does not address three interrelated questions that are central to governance:”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationreasoning

    The same governance logic may extend to omics-based clinical AI models.

    “Although the present study focused on EHR-, laboratory-, and imaging-derived systems, the same governance logic may extend to omics-based clinical AI models.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Omics inputs are not passively observed biological facts; they are generated through laboratory and bioinformatic workflows involving sample handling, sequencing or assay platforms, reagent lots, read depth or coverage, normalization, batch correction, and pipeline versions.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    The study does not attempt to evaluate compliance with specific regulatory frameworks or to prescribe regulatory thresholds.

    “while the study engages with regulatory and governance concepts, it does not attempt to evaluate compliance with specific regulatory frameworks or to prescribe regulatory thresholds.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The analyses focus on detection and characterization of degradation rather than on organizational responses once degradation is identified.

    “The analyses focus on detection and characterization of degradation rather than on organizational responses once degradation is identified.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    If degradation is driven by workflow evolution, documentation changes, or data pipeline failures, then responsibility for safety cannot reside solely with model developers.

    “If degradation is driven by workflow evolution, documentation changes, or data pipeline failures, then responsibility for safety cannot reside solely with model developers.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premiseown data

    Deployment evidence consistently highlights context sensitivity, calibration limitations, and workflow dependence across clinical AI.

    “Table 7 shows that deployment evidence consistently highlights context sensitivity, calibration limitations, and workflow dependence across clinical AI.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premiseown data

    Operational telemetry data are already collected by most clinical systems, as shown in Table 7, but are rarely analyzed in relation to model safety.

    “These data are already collected by most clinical systems, as shown in Table 7, but are rarely analyzed in relation to model safety.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisenone given

    As summarized in Table 7, real-world evidence remains fragmented regarding when degradation begins, which signals detect it, and how governance constraints such as label latency limit observability.

    “However, as summarized in Table 7, it remains fragmented regarding when degradation begins, which signals detect it, and how governance constraints such as label latency limit observability.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationreasoning

    The present study supports a telemetry-first monitoring paradigm, in which label-independent signals are used for early warning and triage, while outcome-based reassessment serves as confirmatory evidence rather than the sole trigger for action.

    “The present study supports a telemetry-first monitoring paradigm, in which label-independent signals are used for early warning and triage, while outcome-based reassessment serves as confirmatory evidence rather than the sole trigger for action.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    The study intentionally abstracts across multiple clinical tasks and data modalities.

    “The study intentionally abstracts across multiple clinical tasks and data modalities.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    For omics-based models, the relevant telemetry signals were outside the empirical scope of the present analysis.

    “For omics-based models, relevant telemetry may include assay platform, reagent batch, sample quality, sequencing depth, normalization procedures, batch-correction methods, and bioinformatic pipeline version; these were outside the empirical scope of the present analysis.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationreasoning

    The study shifts emphasis from cross-site transportability toward within-site temporal fragility and motivates telemetry-informed, calibration-aware monitoring over outcome-centric audits as the basis for lifecycle assurance.

    “The study shifts emphasis from cross-site transportability toward within-site temporal fragility and motivates telemetry-informed, calibration-aware monitoring over outcome-centric audits as the basis for lifecycle assurance.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    Real-world evidence on clinical AI has expanded beyond retrospective validation to external audits, prospective deployments, and workflow-level evaluations.

    “Real-world evidence on clinical AI has expanded beyond retrospective validation to external audits, prospective deployments, and workflow-level evaluations.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Telemetry-first monitoring reduces dependence on potentially contaminated outcome labels for early safety surveillance, though it does not solve the causal problem of label feedback.

    “Telemetry-first monitoring does not solve this causal problem, but it reduces dependence on potentially contaminated outcome labels for early safety surveillance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    The study's findings are relevant for organizational governance and quality assurance, particularly in informing how monitoring systems might be designed to align with lifecycle-oriented regulatory expectations.

    “The findings are relevant for organizational governance and quality assurance, particularly in informing how monitoring systems might be designed to align with lifecycle-oriented regulatory expectations.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    These adaptive responses and feedback mechanisms were not modeled explicitly.

    “These adaptive responses and feedback mechanisms were not modeled explicitly.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    Label latency and policy-dependent outcomes are acknowledged but seldom incorporated into evaluation design.

    “Label latency and policy-dependent outcomes are acknowledged but seldom incorporated into evaluation design.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationown data

    These findings support treating validation as a baseline operating reference rather than a durable safety guarantee.

    “These findings support treating validation as a baseline operating reference rather than a durable safety guarantee.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisereasoning

    Diagnostic confirmation, sepsis adjudication, and specialist grading are typically delayed days to weeks, and downstream outcomes may lag months, so evaluations often identify failures retrospectively rather than enabling early detection.

    “Diagnostic confirmation, sepsis adjudication, and specialist grading are typically delayed days to weeks, and downstream outcomes may lag months, so evaluations often identify failures retrospectively rather than enabling early detection.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    External audits demonstrate that validation performance does not guarantee acceptable real-world behavior, while prospective and workflow-oriented studies indicate that clinician interaction and operational integration materially shape outcomes.

    “External audits (e.g., ESM, EDI) demonstrate that validation performance does not guarantee acceptable real-world behavior, while prospective and workflow-oriented studies (e.g., TREWS, RapidAI) indicate that clinician interaction and operational integration materially shape outcomes.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    The clinical relevance of calibration drift was interpreted through its effect on absolute risk estimation and threshold-based decision-making rather than through measured clinician acceptability.

    “The clinical relevance of calibration drift was interpreted through its effect on absolute risk estimation and threshold-based decision-making rather than through measured clinician acceptability.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data

    The study did not include prospectively elicited clinician tolerance thresholds for performance degradation or direct measures of clinician trust, reliance, or abandonment over time.

    “The study did not include prospectively elicited clinician tolerance thresholds for performance degradation or direct measures of clinician trust, reliance, or abandonment over time.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    This label feedback can bias outcome-dependent reassessment and make delayed labels difficult to interpret as independent ground truth.

    “This can bias outcome-dependent reassessment and make delayed labels difficult to interpret as independent ground truth.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Quantitative effect sizes and degradation rates from this study should not be interpreted as universal.

    “quantitative effect sizes and degradation rates should not be interpreted as universal.”
    Quote in the paperNot a substantial claim
58 of 58
  • The paper relies on this without support.

    The four included AI systems are representative of clinically deployed AI systems in general, such that findings about post-deployment fragility generalize to other systems and settings.

    “The included systems spanned heterogeneous clinical domains, data modalities, and workflow contexts, including high-frequency EHR-based predictive models and lower-frequency diagnostic and imaging-based applications.”
  • The paper relies on this without support.

    Operational telemetry indicators (input missingness, data latency, feature availability) validly capture workflow-induced drift and are not merely proxies for other unmeasured factors.

    “Workflow-induced drift was assessed using operational indicators such as input missingness, data latency, and feature availability.”
  • The paper relies on this without support.

    The validation-era performance metrics are a valid baseline for comparison, and the validation data are comparable to deployment data except for the factors studied.

    “The study compared model performance observed during pre-deployment validation with performance measured after deployment”
  • The paper relies on this without support.

    Outcome labels derived from routine clinical documentation are accurate and consistent enough to serve as ground truth for performance evaluation.

    “Outcome labels were derived from routine clinical documentation and were consistent with those used during validation.”
  • The authors state this as an assumption.

    Outcome labels are assumed unavailable for real-time safety monitoring.

    “Labels delayed days-months, task-dependent, assumed unavailable for real-time safety monitoring.”
  • The paper relies on this without support.

    The four clinically deployed AI systems studied are representative enough that the identified failure modes generalize to other clinical AI systems.

    “The analysis is explicitly designed to mirror the observability conditions documented in Table 7 and to extract generalizable failure structures while grounding them in empirical effect magnitudes observed under routine deployment conditions.”
  • The authors state this as an assumption.

    Current practice often treats acceptable discrimination and calibration at validation as sufficient justification for deployment, with the implicit assumption that performance will remain stable unless the model is explicitly updated.

    “Current practice often treats acceptable discrimination and calibration at validation as sufficient justification for deployment, with the implicit assumption that performance will remain stable unless the model is explicitly updated.”
  • The paper relies on this without support.

    Calibration governs the correctness of absolute risk estimates that underpin threshold-based decisions, escalation pathways, and clinical trust.

    “calibration governs the correctness of absolute risk estimates that underpin threshold-based decisions, escalation pathways, and clinical trust.”
  • The paper relies on this without support.

    Much existing guidance implicitly prioritizes monitoring for population drift, including changes in demographics, case mix, or disease prevalence.

    “Much existing guidance implicitly prioritizes monitoring for population drift – changes in demographics, case mix, or disease prevalence.”
  • The paper relies on this without support.

    The clinical consequences of calibration drift differ between early warning systems, autonomous diagnostic tools, and workflow acceleration platforms.

    “the clinical consequences of calibration drift differ between early warning systems, autonomous diagnostic tools, and workflow acceleration platforms.”
  • The paper relies on this without support.

    The availability and reliability of telemetry signals may vary by modality and vendor implementation.

    “the availability and reliability of telemetry signals may vary by modality and vendor implementation.”
  • The paper relies on this without support.

    In real deployments, health systems may intervene through recalibration, workflow modification, retraining, or temporary suspension, potentially altering observed trajectories.

    “In real deployments, health systems may intervene through recalibration, workflow modification, retraining, or temporary suspension, potentially altering observed trajectories.”
  • The paper relies on this without support.

    Omics inputs are not passively observed biological facts; they are generated through laboratory and bioinformatic workflows involving sample handling, sequencing or assay platforms, reagent lots, read depth or coverage, normalization, batch correction, and pipeline versions.

    “Omics inputs are not passively observed biological facts; they are generated through laboratory and bioinformatic workflows involving sample handling, sequencing or assay platforms, reagent lots, read depth or coverage, normalization, batch correction, and pipeline versions.”
  • The paper relies on this without support.

    Few published studies document not only when degradation occurs, but also how organizations respond and with what effectiveness.

    “few published studies document not only when degradation occurs, but also how organizations respond and with what effectiveness.”
14 of 14

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kopanitsa, G.
Affiliations
ITMO University (RU)
Corresponding author
Kopanitsa, Georgy
Venue
PLOS Digital Health
Published
2026-07-27
Volume
5
Issue
7
Pages
e0001534
ISSN
2767-3170 (ISSN-L)
OpenAlex
W7171376340
Cited by
3
References
33
Citations by year
2026: 3
FWCI
5.68
Type
journal article
Language
en
Open access
Locations
  • PLOS Digital Health (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
  • Social Sciences › Safety Research › Ethics and Social Impacts of AI
Keywords
clinical AI, calibration drift, data availability, data latency, AI governance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-13.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-13.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review